Is Breast Cancer in Asian and Asian American Women a Different Disease? Read more about Is Breast Cancer in Asian and Asian American Women a Different Disease?
Genome-Wide Association Study of Susceptibility Loci for T-Cell Acute Lymphoblastic Leukemia in Children. Read more about Genome-Wide Association Study of Susceptibility Loci for T-Cell Acute Lymphoblastic Leukemia in Children.
Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma. Read more about Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma.
Association of Indoor Tanning Exposure With Age at Melanoma Diagnosis and BRAF V600E Mutations. Read more about Association of Indoor Tanning Exposure With Age at Melanoma Diagnosis and BRAF V600E Mutations.
Factors That Explain Differences in Abstinence Between Black and White Smokers: A Prospective Intervention Study. Read more about Factors That Explain Differences in Abstinence Between Black and White Smokers: A Prospective Intervention Study.
Targeted Genomic Profiling of Acral Melanoma. Read more about Targeted Genomic Profiling of Acral Melanoma.
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis. Read more about Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis.
Trends in Clinical Breast Density Assessment From the Breast Cancer Surveillance Consortium. Read more about Trends in Clinical Breast Density Assessment From the Breast Cancer Surveillance Consortium.
Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Read more about Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer.
Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer. Read more about Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer.
